![TECHNOLOGICAL FEAT: The underside of the new insole using Augmented Vibrotexture. TECHNOLOGICAL FEAT: The underside of the new insole using Augmented Vibrotexture.](/images/transform/v1/crop/frm/ezJUJGp6GbYvhKygBYtWTb/63da75fb-7e8e-4df7-89d6-46e38644d0de.jpg/r0_0_600_292_w1200_h678_fmax.jpg)
A shoe insole using bionic technology to help people with nerve damage maintain their balance has been designed by University of Queensland researchers.
Create a free account to read this article
$0/
(min cost $0)
or signup to continue reading
Anna Hatton from UQ's School of Health and Rehabilitation Sciences said the technology was designed to help facilitate safe, active and independent living.
"One in six people will experience foot sensory loss due to numerous types of neuropathy and up to 65 per cent of people with this nerve damage will fall each year," Dr Hatton said.
"Our new bionic technology called Augmented Vibrotexture is a hybrid design combining vibration and geometric texture into an insole, which provides stimuli to the soles of the feet.
"This provides feedback along major sensory nerves that carry signals about touch, vibration and position sense from the feet to the brain to help maintain balance.
"This is the first time a shoe insole has been developed with a hybrid design like this that provides two different types of sensory stimuli."
The insoles are operated by a mobile app that tracks the user's health and also allows remote health monitoring between patients and clinicians.
The invention was recently awarded the major category prize in this year's Bionics Challenge, receiving $50,000 in prize money and an eight-week mentoring program.
Dr Hatton said the funds will be used to help develop design features, the mobile app and to test the final prototype.
Her team plans to develop a wide product range that will include insoles for people with neuropathy, those with balance issues due to other medical conditions and a product that targets general health and well-being.
The team is collaborating with academics, clinicians and industry partners in Queensland and NSW along with Walk With Path in Copenhagen and London to co-develop this novel bionic sensory insole technology.